Grow your brand, now and through patent expiry This blog is part of an ongoing series on A Brave New World: Therapeutic Area Deep Dives
Reducing dietary fat intake, particularly avoiding high-fat meals, can minimise digestive stress for those without a gallbladder whilst also reducing nausea and bloating associated with the medication
[78] found that Lira inhibited proprotein convertase subtilisin/kexin type 9 (PCSK9) expression in HepG2 cells and db/db mice through hepatocyte nuclear factor 1 (HNF1)-dependent mechanism, and may inhibit LDLR expression in db/db mice through PCSK9 independent pathway, and ultimately reduce liver cholesterol accumulation
The labeling for phentermine also contains a candid statement rarely quoted: the limited usefulness of agents of this class should be measured against possible risk factors inherent in their use
Changes in Lean Body Mass with Glucagon-Like Peptide-1-Based Therapies and Mitigation Strategies. Diabetes, Obesity and Metabolism , vol
However, even though alloxan did not inhibit the GLUT2 transporter function 29 , in this study, no alteration in GLUT2 levels was seen after administration of the QV formulation